Protein Kinase A Inhibitor H89 Attenuates Experimental Proliferative Vitreoretinopathy

PURPOSE: This study aimed to explore the role of the protein kinase A (PKA) pathway in proliferative vitreoretinopathy (PVR) and the effect of the PKA inhibitor H89 on experimental PVR. METHODS: Epiretinal membranes (ERMs) were acquired from PVR patients and analyzed by frozen-section immunofluoresc...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Invest Ophthalmol Vis Sci
Päätekijät: Lyu, Yali, Xu, Wei, Zhang, Jieping, Li, Mengwen, Xiang, Qingyi, Li, Yao, Tan, Tianhao, Ou, Qingjian, Zhang, Jingfa, Tian, Haibin, Xu, Jing-Ying, Jin, Caixia, Gao, Furong, Wang, Juan, Li, Weiye, Rong, Ao, Lu, Lixia, Xu, Guo-Tong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Association for Research in Vision and Ophthalmology 2020
Aiheet:
Retinal Cell Biology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7325625/
https://ncbi.nlm.nih.gov/pubmed/32031573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.61.2.1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia